Study: Key hormone therapy trial was flawed
16th Dec 2005, 15:25 GMT
A 2002 study showing that hormone replacement therapy raises the risk of heart disease and breast cancer was fundamentally flawed, according to new research.
Study: Key hormone therapy trial was flawed related news:
- Study says pivotal hormone therapy trial was flawed (Reuters) — Yahoo! News: Health News
- Study says pivotal hormone therapy trial was flawed — Reuters: Health
- Study That Discredited HRT Was Flawed, Experts Say (HealthDay) —
- Study: hormone helps men with Alzheimers — United Press International - Health Business
- San Antonio Breast Cancer Symposium Research Shows Hormone Replacement Therapy is No Help for Women Taking Tamoxifen — Mammography News from StratCenter.com
- Hormone Replacement For Alzheimer's Patients — cbs2chicago.com: Chicago news, weather, traffic, video from WBBM-TV: Health
- US trial 'is flawed' — KeralaNext: US
- BTG to study novel therapy for sleep apnea — Pharmaceutical Business Review Online
- Hormone replacement therapy and venous thromboembolism. — National Guideline Clearinghouse (NGC)
- USA: Ahmed Abu Ali trial flawed by exclusion of Saudi torture evidence — Amnesty International USA: Most Recent English News Releases
Latest news from MSNBC.com: Health:
- Hospitals race to improve heart attack care
- Diabetes drug may cut heart risks
- U.S. kids getting hardened arteries
- Mixed reviews for Vioxx successor
- Red meat raises breast cancer risk
- Genes may determine who survives trauma
- Drug-covered balloon to open arteries?
- Tamiflu takers: Watch out for bizarre behavior
- Backlash from too much flu vaccine?
- Diseased gums raise risk of pancreatic cancer